Fact CheckerSign in

NCT07199946RecruitingPhase 1/2

A Phase I/II Double-blind, randomized, placebo-controlled trial to preserve residual insulin secretion in children with recent onset Type 1 diabetes by giving oral Verapamil

Source: EU CTIS (euclinicaltrials.eu) · Last updated 11 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

To evaluate the effect on preservation of residual beta cell function by treatment with Verapamil

Status (registry)
Recruiting
Phase (registry)
Phase 1/2
Study type
Interventional
Enrollment
36 (estimated)
First submitted
7 Nov 2024
Start date
6 Aug 2025
Lead sponsor
Linkopings Universitet
EU CT number
2024-515106-30-00

What you commit to

  • Study type: Interventional · Phase 1/2
  • Planned participants: 36
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous or current treatment with immunosuppressant therapy (although topical or inhaled steroids are accepted)

Other illness

  • Cardiac disease/problems, abnormal ECG, or history of abnormal blood pressure

Who the study is looking for

  • Informed consent given by patients and caregivers/parents
  • Type 1 diabetes according to the ADA classification within the previous 3 months at the time of screening
  • Fasting C-peptide >0.12 nmol/ml
  • Elevated levels of any diabetes-related antibody/ies (e.g. GADA, IAA, IA-2A, ZnT8A) is/are present
  • Age 4.00 - 9.99 years at Diagnosis of Type 1 diabetes

Age in the registry: - to 17 years · Sex: All · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Region Joenkoepings Laen
Coordinator of this site? Confirm its status
JonkopingSwedenRecruiting
Region Oestergoetland
Coordinator of this site? Confirm its status
LinkopingSwedenRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.